CCR7, expressed in various lymphoid tissues, activates B and T lymphocytes and facilitates tumor cell migration by mediating interactions between tumor cells and chemokines CCL19/CCL21, and may enhance tumor cell anti-apoptotic capacity through regulation of necroptosis-related gene expression (48). This evidence concerns the gene CCL21 and neoplasm.